Updated:
Opus 8
Opus 8 was established in 2002 by S. Tien Wong following the 2003 sale of CyberRep, the call-center operator he co-founded in 1991. Wong serves as Chairman and...
Opus 8
Opus 8 was established in 2002 by S. Tien Wong following the 2003 sale of CyberRep, the call-center operator he co-founded in 1991. Wong serves as Chairman and CEO and remains the central figure directing both investment and advisory activities. The firm invests directly and through syndicates in life sciences, healthcare services, and tech-enabled businesses. It covers buyout, early-stage, and venture capital opportunities across North America, Europe, Asia, South America, and Oceania. Confirmed activity includes commitments to private equity, venture capital, and hedge fund vehicles alongside direct co-investments. The firm also leads capital-raising road shows for managers targeting family-office and institutional LPs. Opus 8 maintains a small team that includes business analysts and community managers supporting both investment screening and event operations. Wong holds additional roles as Venture Partner at IronGate Capital Advisors and as a board member or advisor to several regional venture and entrepreneurship organizations. No recent operational events from the last 24 months appear in public records. A structural feature is the integration of investment activity with operating businesses that produce proprietary deal flow. The firm runs the CONNECTpreneur conference series and separate road-show programs that give it recurring access to managers and companies seeking capital.
General information
Firm type
Multi Family Office
Year founded
2002
Location
Region
North America
Country
United States
City
Cincinnati
Corporate office
McLean, VA, United States
Principals
S. Tien Wong
Chairman & CEO
Sector focus
Frequently asked questions
Who runs investment decisions at Opus 8?
S. Tien Wong serves as Chairman and CEO and directs investment and advisory activity. He previously founded and sold CyberRep and maintains board roles at several venture and technology organizations.
How does Opus 8 source proprietary deal flow?
The firm operates the CONNECTpreneur conference series and leads global fundraising road shows for private equity, venture, and hedge fund managers. These programs create direct access to companies and managers seeking capital.
Does Opus 8 participate in fund commitments or only direct deals?
Opus 8 makes both direct and syndicated investments and also commits to private equity, venture capital, and hedge fund vehicles. It structures activity through alternative VC models and co-investment SPVs.
What investment stages does Opus 8 typically target?
The firm targets buyout, early-stage, and venture capital opportunities. It focuses on life sciences, healthcare services, and tech-enabled companies.
Where does the underlying wealth come from?
The firm grew from proceeds of the 2003 sale of CyberRep, the CRM outsourcing company founded by Chairman S. Tien Wong.
Does Opus 8 maintain philanthropic structures, and how are they separated?
No separate philanthropic vehicles are disclosed. Wong serves on boards of several nonprofit and entrepreneurship organizations in a personal capacity.
What is Opus 8's known posture on co-investments alongside external GPs?
The firm participates in direct co-investments and syndicates alongside other investors while also committing to external funds. It provides advisory services to managers on capital raising and strategy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: